Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Novo Nordisk connected Monday said it has chopped the direct-to-consumer prices of its blockbuster value nonaccomplishment cause Wegovy and diabetes counterpart Ozempic, adding to efforts by the institution and the Trump administration to marque the treatments much accessible. 

The Danish drugmaker is lowering the terms of the drugs for existing cash-paying patients to $349 per period from $499 per month. But Novo Nordisk said the cash-pay outgo of the highest dose of Ozempic volition stay $499 per month. 

Also connected Monday, Novo Nordisk launched a impermanent introductory offer, which volition let caller cash-paying patients to entree the 2 lowest doses of Wegovy and Ozempic for $199 per period for the archetypal 2 months of treatment. After that period, radical determination to the caller modular monthly direct-to-consumer price. The company's introductory connection ends connected March 31. 

The announcements travel days aft President Donald Trump struck deals with Novo Nordisk and main rival Eli Lilly to marque their fashionable GLP-1 drugs easier for Americans to entree and afford. Those agreements volition impact cutting the prices the authorities pays for the drugs, introducing Medicare sum of obesity drugs for the archetypal clip for definite patients and offering discounted medicines connected the government's caller direct-to-consumer website launching successful January called TrumpRx. 

"Our caller savings offers supply contiguous impact, bringing guardant greater cost savings for those who are presently without sum oregon take to self-pay," said Dave Moore, Novo Nordisk's caput of U.S. operations, said successful a release. "It is portion of a larger strategy to grow entree that includes gathering relationships with telehealth providers and large retailers, expanding coverage, and moving with the Administration to little costs for radical surviving with chronic diseases similar obesity."

The Trump medication said starting doses of existing injections similar Wegovy and Eli Lilly's value nonaccomplishment cause Zepbound volition beryllium $350 per period connected TrumpRx, but volition "trend down" to $245 per period implicit a two-year period. 

On the time the deals were announced, Eli Lilly said it would little prices by $50 connected its ain direct-to-consumer platform, LillyDirect, which already offers Zepbound astatine a discount to cash-paying patients. The multidose pen of Zepbound volition beryllium disposable astatine $299 per period astatine the lowest dose, with further doses being priced up to $449 per month.

Novo Nordisk's caller cash-pay offers are disposable done Wegovy.com oregon Ozempic.com, the company's direct-to-consumer pharmacy, NovoCare, and different participating organizations and telehealth providers that enactment straight with the drugmaker, including Costco, GoodRx, WeightWatchers, Ro, LifeMD and eMed.